Clinical trial Recruiting at 1 site Observational Ages 18 to 99

Continuous ESP Block vs Thoracic Epidural for Preventing Chronic Pain After Thoracotomy

Official title: Continuous Erector Spinae Block Versus Thoracic Epidural Analgesia for the Prevention of Chronic Pain Following Thoracotomy: a Retrospective Study

Run by Meir Medical Center · NCT07677540 · Data updated 2026-11-12

This study compares whether a continuous erector spinae plane block can better prevent chronic post-thoracotomy pain than the current standard thoracic epidural analgesia in adults undergoing elective thoracic surgery.

Quick facts

Study typeObservational
Ages18 Years to 99 Years
SexAll
Enrollment34 (estimated)
SponsorMeir Medical Center
Academic / other
Locations1 site (Kfar Saba)
StatusRecruiting
StartedSeptember 12, 2023
Main results expectedJuly 1, 2027
Study endsJuly 31, 2027
Registry record updatedOctober 7, 2026
Trial IDNCT07677540 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18-65 undergoing elective thoracic surgery who receive either ESP block or TEA before anesthesia at Meir Medical Center.

Probably not a fit

Patients who do not experience a reduction in chronic pain or who have pain driven by factors unrelated to the anesthesia technique may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is an observational study evaluating two anesthesia techniques—continuous erector spinae plane block and thoracic epidural analgesia—for preventing chronic pain after thoracic surgery. The analysis focuses on the incidence of post-thoracotomy pain syndrome, as well as postoperative pain levels, analgesic use, and technique-related complications. Eligible participants were adults aged 18-65 undergoing elective thoracic surgery and receiving either ESP block or TEA before surgery. The study is conducted at Meir Medical Center in Kfar Saba and does not indicate randomization or prospective intervention beyond standard clinical practice. Findings may inform whether ESP block offers comparable or superior long-term pain outcomes relative to TEA in this surgical population.

Why it matters

Potential benefit: If ESP block reduces the risk of chronic pain after thoracotomy, patients could experience less long-term pain and improved recovery.

How similar studies have gone: There is existing interest in comparing ESP blocks to TEA, but evidence on chronic pain prevention is still evolving and varies by study design.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1\. Ages 18-65 years 2. Presenting for elective thoracic surgery under general anesthesia. 3. Undergoing either ESP or TEA prior to surgery.

\-

Exclusion Criteria:Patients were excluded if they met any of the following criteria:

1\. Any CNS and/or psychiatric disease. 2. Patients who are unable to complete the pain survey for any reason. 3. Patients who had baseline chronic pain around the surgical incision.

\-

Where it's running

  • Meir Medical Center
    Kfar Saba, Israel
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.